Jeffrey Smith - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>PC</div>
PRGO -- USA Stock  

Last Earning Announcement: 31st of December 2015  

Mr. Jeffrey C. Smith is Independent Director of the Company. Mr. Smith is a Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP. Mr. Smith has extensive experience in bestinclass corporate governance practices and significantly improving value at underperforming companies. He currently serves as Chairman of the board of Advance Auto Parts, where he was a director since November 2015 and as a director and Chairman of the board of Papa Johns Pizza since February 2019. Mr. Smith was Chairman of the board of Darden Restaurants from October 2014 to April 2016 and a director of Yahoo Inc. from April 2016 to June 2017. In addition, during the past five years, Mr. Smith has served on the boards of Quantum Corporationrationration and Office Depot, Inc.
Age: 45  Director Since 2017      
353 1 709 4000

Jeffrey Smith Latest Insider Activity

Perrigo Company Management Efficiency

Perrigo Company has return on total asset (ROA) of 2.63 % which means that it generated profit of $2.63 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 3.28 %, meaning that it created $3.28 on every $100 dollars invested by stockholders. Perrigo Company management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.
The company currently holds 3.6 B in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Perrigo Company has a current ratio of 1.82, which is within standard range for the sector.

Similar Executives

Showing few of many executives


Sanjay KhoslaZoetis Inc
Anupam PuriDr Reddys Laboratories
Joseph BoccuziAllergan Plc
Nesli BasgozAllergan Plc
Thomas FreymanAllergan Plc
Fred WeissAllergan Plc
Prasad MenonDr Reddys Laboratories
Elaine UllianVertex Pharmaceuticals Incorpor
Paul BisaroZoetis Inc
Bharat DoshiDr Reddys Laboratories
Scott GottliebPfizer Inc
James QuinceyPfizer Inc
Margaret McGlynnVertex Pharmaceuticals Incorpor
Linda RhodesZoetis Inc
Huda ZoghbiRegeneron Pharmaceuticals
Ronald TaylorAllergan Plc
Helen HobbsPfizer Inc
Peter McDonnellAllergan Plc
Carol DavidsonAllergan Plc
Robert ScullyZoetis Inc
Ashok GangulyDr Reddys Laboratories

Company Summary

Perrigo Company plc manufactures and supplies over-the-counter health and wellness solutions in the United States, Europe, and internationally. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on BATS Exchange. It employs 11000 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 11,000 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Current Sentiment - PRGO

Perrigo Company Investor Sentiment

Most of Macroaxis users are at this time bullish on Perrigo Company Plc. What is your perspective on investing in Perrigo Company Plc? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Sold over 300 shares of
six days ago
Traded for 8.62
Sold over 100 shares of
six days ago
Traded for 25.24
Sold over 60 shares of
six days ago
Traded for 44.08
Sold over 100 shares of
six days ago
Traded for 28.82
Sold few shares of
six days ago
Traded for 206.26
Please check Your Equity Center. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page